What Cannabis Patent Applicants Can Learn From Biopharma

By Pauline Pelletier and Deborah Sterling (January 17, 2019, 12:48 PM EST) -- Today the cannabis industry is booming and analysts have projected that it will grow from $9.2 billion in 2017 to $47.3 billion in 2027 in North America alone.[1] This past year saw the first U.S. Food and Drug Administration-approved drug comprised of an active ingredient derived from cannabis.[2] It also saw the first patent infringement suit involving a cannabis-related patent.[3] And in just the first month of 2019 we have seen the first decision in a post-grant proceeding involving a cannabis-related patent[4] as well as legislation for legalizing and regulating cannabis introduced in the House of Representatives.[5]

The arms race for...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!